Categories: EHRHealthcareNews

Medsender Achieves SOC 2 Type II Certification

Independent Audit Confirms Medsender’s Platform Meets Rigorous Data Security and Operational Controls

NEW YORK, July 8, 2025 /PRNewswire/ — Medsender®, the AI-powered automation platform for healthcare providers, today announced it has completed Service Organization Control 2 Type II (SOC 2 Type II) certification. This rigorous, independent audit confirms that Medsender’s systems and processes meet leading industry standards for safeguarding patient data, without compromising the simplicity and speed that practices depend on.

The SOC 2 Type II report confirms that Medsender’s internal controls are not only well-designed but also consistently implemented and enforced over time. For healthcare providers, this certification provides added confidence that Medsender’s platform is secure, reliable and built to scale while remaining fully HIPAA-compliant.

“Our customers rely on Medsender to streamline operations without compromising on security,” said Zain Qayyum, Medsender founder and co-CEO. “This milestone reflects our belief that automation and trust must go hand in hand. We’ve built a platform that streamlines care delivery by eliminating administrative bottlenecks while ensuring the data behind every patient visit is secure, accurate and accessible.”

Medsender is trusted by thousands of medical practices across all 50 states. The platform uses AI to capture and process information from various sources, including faxes, emails and phone calls, and then delivers it directly into the patient’s record. It automates high-volume, high-stakes processes such as fax management, referral processing and patient communication that often rely too heavily on manual effort. By eliminating those bottlenecks, Medsender helps practices reduce delays, improve chart accuracy and fill their schedules faster.

“SOC 2 Type II isn’t just a badge, it’s proof that our security practices hold up under continuous, third-party scrutiny,” said Mahmoud Tohmaz, chief technology officer at Medsender. “We’ve embedded security into every layer of our infrastructure and operations to ensure our platform scales safely and securely for the healthcare providers who depend on us.”

The company previously achieved SOC 2 Type I certification and maintains full HIPAA compliance. This new Type II certification, conducted by a third-party certified by the American Institute of Certified Public Accountants (AICPA), further validates the company’s commitment to data security and operational integrity.

About Medsender
Medsender® is the AI-powered workflow automation platform for healthcare. It easily integrates with EHR systems and utilizes AI to automate administrative tasks. Its AI voice agent, MAIRA™, streamlines patient communication by accurately managing all inbound patient phone calls and using an authentic human-like voice. Medsender is trusted by thousands of professionals across all 50 states. It serves the entire healthcare ecosystem, including medical practices, healthcare technology companies, and everyone in between. For more information, visit https://www.medsender.com/.

Media Contact:
De Grey
de@medsender.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/medsender-achieves-soc-2-type-ii-certification-302499747.html

SOURCE Medsender

Staff

Recent Posts

MEDITECH Announces the Passing of Founder and Chairman A. Neil Pappalardo

Reflections on his 56-year legacy as a tech pioneer and founder of the EHR industryCANTON,…

1 hour ago

eClinicalWorks and Sunoh.ai Assist Healthy Horizons Clinic Save Over Two Hours Daily on Clinical Documentation

Multispecialty practice transforms patient care, improves operational efficiency, and increases patient engagement with AI medical…

1 hour ago

TRNR Publishes Comprehensive Sportstech Documentation for Shareholders

Timeline and Source Materials Now Available at interactivestrength.com/sportstech AUSTIN, TEXAS / ACCESS Newswire / January…

1 hour ago

KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading…

4 hours ago

Hologic Announces Financial Results for First Quarter of Fiscal 2026

– Revenue of $1,047.8 Million Grows 2.5% – – GAAP Diluted EPS of $0.79 Decreases…

4 hours ago

Illumina completes acquisition of SomaLogic

Deeply expands leadership in proteomics and multiomicsCombined capabilities bring high scalability, flexibility, and affordability into protein…

4 hours ago